Liquidia Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Liquidia Technologies's estimated annual revenue is currently $17.2M per year.
- Liquidia Technologies received $25.5M in venture funding in February 2018.
- Liquidia Technologies's estimated revenue per employee is $155,000
- Liquidia Technologies's total funding is $173.9M.
Employee Data
- Liquidia Technologies has 111 Employees.
- Liquidia Technologies grew their employee count by 41% last year.
Liquidia Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | VP CMC R&D | Reveal Email/Phone |
5 | VP Medical Affairs | Reveal Email/Phone |
6 | VP, Manufacturing Operations | Reveal Email/Phone |
7 | VP, Global Regulatory Affairs | Reveal Email/Phone |
8 | VP Market Access | Reveal Email/Phone |
9 | VP Marketing | Reveal Email/Phone |
10 | Chief Operations Officer | Reveal Email/Phone |
Liquidia Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Liquidia Technologies?
Liquidia Technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. Our proprietary PRINT technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. PRINT technology is a scalable cGMP compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. Liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. Liquidia is advancing product candidates from its own pipeline. These initial product candidates, LIQ861 and LIQ865, apply the PRINT technology to better drug delivery in inhaled and pain therapeutic areas, respectively. The PRINT technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$173.9M
Total Funding
111
Number of Employees
$17.2M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Liquidia Technologies News
The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has...
and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial...
and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial...
A biotechnology company based in the Research Triangle Park has raised $50 million in an initial public offering. Morrisville-based Liquidia Technologies Inc. sold 4.5 million shares at a price of $11 per share. When it initially filed for its IPO, the company had hoped to raise $57.5 million. ...
A biotechnology company based in the Research Triangle Park has filed to raise $57.5 million in an initial public offering, according to a filing Thursday with the Securities and Exchange Commission. Morrisville-based Liquidia Technologies Inc. is a nanotechnology company that designs, develops ...
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.6M | 112 | -1% | N/A |
#2 | $16.2M | 112 | 7% | N/A |
#3 | $33.6M | 116 | 4% | N/A |
#4 | $24.6M | 117 | 7% | N/A |
#5 | $32.4M | 120 | 56% | N/A |
Liquidia Technologies Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2006-06-15 | $6.0M | Undisclosed | Wakefield Group | Article |
| 2007-03-05 | $16.0M | Undisclosed | New Enterprise Associates | Article |
| 2009-08-03 | $7.0M | Undisclosed | Article | |
| 2009-12-18 | $3.0M | Undisclosed | National Institute of Standard | Article |
| 2010-01-20 | $20.0M | C | Canaan Partners | Article |
| 2010-04-21 | $Undisclosed | C | PPD Inc | Article |
| 2014-09-11 | $10.0M | A | Canaan Partners | Article |
| 2018-02-21 | $25.5M | Undisclosed | Article |